Search

everythinglearnresearchcommunity

for

Search:↓

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

Red ginseng extract (GS-E3D) may promote hair growth and has antioxidant and anti-inflammatory properties.

The treatment was effective and tolerable for advanced gastric cancer.

Minimally invasive glaucoma surgery can effectively manage glaucoma in GAPO syndrome when other treatments fail.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Sox13 is a marker for early hair follicle development but not essential for skin and hair growth.

GI197111X is best dissolved in Capmul MCM for trials.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.

Targeting Sirt1 can reduce androgen levels and slow glioblastoma growth.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

Newer GLP-1 drugs like semaglutide may cause hair loss.

GRF is not safe for tubal occlusion.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Ritlecitinib is an effective new treatment for Alopecia Areata.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Zinc sulfide cellulose scaffolds can reduce scarring and promote hair growth.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.